月K · MACD · 年ROE Monthly Trend · 美元
MACD(12,26,9)
MACD · 前复权口径
年ROE（每份年报一根整柱，柱宽 = 生效期：报告期 + 4 个月起）
加载中…
获利能力 Profitability (单位：美元)
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 净资产收益率（ROE） | - | -164.81% | 31.85% | 49.93% | 94.78% | 5.14% | 11.85% | -14.12% | 1.71% | -20.86% | -34.66% | -521.48% | -78.20% | 80.22% | -205.14% | 173.11% | 37.88% | 44.44% | 110.75% | 33.54% | 17.53% | 34.42% |
| 总资产收益率（ROA） | - | -1.06% | 0.31% | 2.28% | 13.16% | 0.69% | 1.56% | -0.81% | 0.07% | -0.59% | -0.78% | -3.01% | 0.46% | -0.92% | 1.47% | 3.31% | 1.51% | 2.16% | 11.06% | 4.74% | 2.42% | 4.98% |
| 毛利率 | 82.24% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| 净利率 | -10.33% | -1.04% | 0.37% | 2.37% | 13.94% | 1.09% | 1.46% | -0.94% | 0.46% | 0.42% | 0.90% | -1.67% | 2.51% | 0.93% | 4.35% | 7.58% | 5.22% | 6.38% | 19.66% | 11.11% | 10.90% | 16.50% |
| 每股收益（EPS） | -1.71 | -0.19 | 0.05 | 0.38 | 9.24 | 0.49 | 1.35 | -1.32 | 0.12 | -1.41 | -1.93 | -7.00 | 1.02 | -2.08 | 3.80 | 8.55 | 3.84 | 6.01 | 33.02 | 15.61 | 7.49 | 17.94 |
财务结构 Financial Structure
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 现金占总资产比率 | - | 6.82% | 6.20% | 8.68% | 4.76% | 1.34% | 4.02% | 0.69% | 1.08% | 1.50% | 2.90% | 2.61% | 1.83% | 1.12% | 9.02% | 8.57% | 3.16% | 4.34% | 10.43% | 9.71% | 9.15% | 7.07% |
| 负债占总资产比率 | - | 99.36% | 98.20% | 91.24% | 78.60% | 82.18% | 86.36% | 92.60% | 93.39% | 86.39% | 85.93% | 89.72% | 90.60% | 91.68% | 89.34% | 84.56% | 83.03% | 80.55% | 70.46% | 69.76% | 71.07% | 71.64% |
经营能力 Operating Capability
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 应收账款周转率(次) | - | 5.84 | 6.42 | 7.18 | 7.23 | 6.77 | 6.78 | 5.87 | 6.91 | 7.44 | 6.77 | 7.33 | 7.06 | 6.74 | 6.56 | 7.03 | 6.52 | 7.06 | 8.15 | 8.31 | 4.14 | 4.22 |
| 平均收现日数 | - | 63 天 | 57 天 | 51 天 | 50 天 | 54 天 | 54 天 | 62 天 | 53 天 | 49 天 | 54 天 | 50 天 | 52 天 | 54 天 | 56 天 | 52 天 | 56 天 | 52 天 | 45 天 | 44 天 | 88 天 | 87 天 |
| 固定资产周转率(次) | - | 0.5747 | 0.4998 | 0.5185 | 0.5208 | 0.5027 | 0.4708 | 0.6839 | 0.4658 | 0.3936 | 0.4104 | 0.3665 | 0.3819 | 0.3722 | 0.3794 | 0.3298 | 0.3370 | 0.3032 | 0.2926 | 0.2963 | 0.5740 | 0.5691 |
| 总资产周转率 | - | 96.31% | 105.03% | 104.59% | 97.24% | 102.27% | 100.83% | 67.40% | 92.49% | 84.92% | 79.43% | 82.01% | 81.72% | 79.09% | 65.08% | 70.65% | 70.61% | 72.63% | 71.45% | 71.81% | 36.57% | 35.85% |
现金流量 Cash Flow (单位：亿美元)
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 现金及现金等价物 | - | 5.72 | 5.07 | 6.90 | 4.05 | 1.13 | 3.64 | 1.13 | 1.93 | 3.56 | 7.16 | 6.11 | 4.11 | 2.62 | 24.46 | 23.64 | 8.58 | 12.28 | 30.19 | 28.83 | 26.25 | 21.70 |
| 净利润 | -8.03 | -0.89 | 0.25 | 1.81 | 11.19 | 0.58 | 1.41 | -1.34 | 0.12 | -1.40 | -1.92 | -7.04 | 1.04 | -2.15 | 3.99 | 9.14 | 4.11 | 6.11 | 32.00 | 14.07 | 6.94 | 15.28 |
| 经营活动现金流量 | -4.62 | 3.26 | 2.08 | 4.25 | 4.72 | 4.97 | 5.93 | 5.89 | 6.87 | 10.26 | 5.58 | 12.00 | 10.49 | 12.33 | 34.07 | 15.68 | 10.83 | 23.74 | 20.47 | 35.40 | 17.51 | 22.26 |
| 投资活动现金流量 | -3.79 | -5.20 | -2.74 | -1.25 | -4.20 | -5.03 | -6.62 | -21.64 | -13.22 | -13.17 | -4.30 | 0.21 | -1.15 | -6.19 | -16.08 | -7.14 | -8.08 | -9.69 | 34.29 | -12.75 | -5.01 | -5.20 |
| 筹资活动现金流量 | 2.52 | -0.18 | 0.01 | -1.17 | -3.37 | -2.86 | 3.20 | 13.24 | 7.15 | 4.54 | 2.32 | -13.26 | -11.34 | -7.63 | 3.85 | -9.36 | -17.81 | -10.35 | -36.85 | -24.01 | -16.44 | -24.19 |
| 净现金流量 | -5.89 | -2.12 | -0.65 | 1.83 | -2.85 | -2.92 | 2.51 | -2.51 | 0.80 | 1.63 | 3.60 | -1.05 | -2.00 | -1.49 | 21.84 | -0.82 | -15.06 | 3.70 | 17.91 | -1.36 | -3.94 | -7.13 |
右侧两列为报告期累计口径同比（左：去年同期同一期次，右：最近一期季报，年报期次已在左侧列展示）；周转率类指标为报告期累计值，未做年化。
医疗保健
- 近五年ROE对比
1
100.00%
PACS Group Inc
次新股
PACS
2
100.00%
ImmunityBio Inc
亏损年份
IBRX
3
100.00%
安进
AMGN
4
100.00%
奥洛兹美医疗
HALO
5
100.00%
Puma Biotechnology Inc
亏损年份
PBYI
6
100.00%
沃特世
WAT
7
100.00%
Picard Medical Inc
数据<5年
亏损年份
次新股
PMI
8
84.37%
IDEXX实验室
IDXX
9
79.94%
泰尼特保健
THC
10
74.93%
礼来
LLY
11
74.56%
诺和诺德
NVO
12
62.37%
BridgeBio Pharma Inc
亏损年份
BBIO
13
52.47%
硕腾
ZTS
14
50.94%
NRC Health
NRC
15
49.16%
Medpace Holdings Inc
MEDP
16
48.89%
葛兰素史克
GSK
17
32.44%
Harmony Biosciences Holdings In
HRMY
18
32.16%
Innoviva Inc
INVA
19
31.55%
强生
JNJ
20
30.84%
默沙东
MRK
21
30.27%
Chemed Corp
CHE
22
29.98%
InMode Ltd
INMD
23
28.48%
西佳科技
SIGA
24
27.65%
爱德华兹生命科学
EW
25
26.99%
诺华制药
NVS
26
25.87%
Catalyst Pharmaceuticals Inc
CPRX
27
24.94%
Molina Healthcare Inc
MOH
28
24.45%
再生元制药
REGN
29
24.38%
吉利德科学
GILD
30
24.35%
瑞思迈
RMD